We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu
Trial record 25 of 204 for:    Oral Cancer | Recruiting Studies | NIH

TRC102 and Temozolomide for Relapsed Solid Tumors and Lymphomas

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01851369
Recruitment Status : Recruiting
First Posted : May 10, 2013
Last Update Posted : December 14, 2017
Information provided by (Responsible Party):
National Institutes of Health Clinical Center (CC) ( National Cancer Institute (NCI) )

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Recruiting
  Estimated Primary Completion Date : December 24, 2019
  Estimated Study Completion Date : December 24, 2019